Entero Therapeutics, Correlations

ENTO Stock

0.40 0.001 0.25%

The current 90-days correlation between Entero Therapeutics, and Sonnet Biotherapeutics Holdings is 0.18 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entero Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entero Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Entero Therapeutics, Correlation With Market

Modest diversification

The correlation between Entero Therapeutics, and DJI is 0.2 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Entero Therapeutics, and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entero Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Entero Stock, please use our How to Invest in Entero Therapeutics, guide.

Moving together with Entero Stock

0.73	EWTX	Edgewise Therapeutics	Pair Corr
0.74	PRAX	Praxis Precision Med	Pair Corr
0.61	ABOS	Acumen Pharmaceuticals	Pair Corr
0.72	AKRO	Akero Therapeutics	Pair Corr
0.65	ALVO	Alvotech	Pair Corr
0.77	AMLX	Amylyx Pharmaceuticals	Pair Corr
0.83	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.61	TLKMF	Telkom Indonesia Tbk	Pair Corr
0.69	SSNLF	Samsung Electronics	Pair Corr

Moving against Entero Stock

0.67	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.62	KURA	Kura Oncology	Pair Corr
0.55	TERN	Terns Pharmaceuticals	Pair Corr
0.52	XFOR	X4 Pharmaceuticals	Pair Corr
0.45	KTTA	Pasithea Therapeutics	Pair Corr
0.44	DYN	Dyne Therapeutics	Pair Corr
0.42	BDRX	Biodexa Pharmaceticals Upward Rally	Pair Corr
0.4	PALI	Palisade Bio	Pair Corr
0.38	INZY	Inozyme Pharma	Pair Corr
0.32	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.31	VRAX	Virax Biolabs Group	Pair Corr
0.58	KO	Coca Cola Aggressive Push	Pair Corr
0.56	TLK	Telkom Indonesia Tbk	Pair Corr
0.5	PPERY	Bank Mandiri Persero	Pair Corr
0.43	PPERF	Bank Mandiri Persero	Pair Corr
0.41	BKRKF	PT Bank Rakyat	Pair Corr

Related Correlations Analysis

	KPRX	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX
KPRX		0.41	0.25	0.14	0.33	-0.33	0.21	KPRX
ZVSA	0.41		0.68	-0.08	0.34	-0.19	-0.05	ZVSA
SONN	0.25	0.68		0.03	0.55	-0.22	-0.02	SONN
ZURA	0.14	-0.08	0.03		0.25	0.54	0.29	ZURA
PHIO	0.33	0.34	0.55	0.25		0.14	-0.14	PHIO
RNAZ	-0.33	-0.19	-0.22	0.54	0.14		-0.03	RNAZ
QNRX	0.21	-0.05	-0.02	0.29	-0.14	-0.03		QNRX
	KPRX	ZVSA	SONN	ZURA	PHIO	RNAZ	QNRX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

SONN	+ 0.68	ZVSA
PHIO	+ 0.55	SONN
RNAZ	+ 0.54	ZURA
ZVSA	+ 0.41	KPRX
PHIO	+ 0.34	ZVSA
PHIO	+ 0.33	KPRX

High negative correlations

RNAZ	- 0.33	KPRX
RNAZ	- 0.22	SONN
RNAZ	- 0.19	ZVSA
QNRX	- 0.14	PHIO
ZURA	- 0.08	ZVSA
QNRX	- 0.05	ZVSA

Risk-Adjusted Indicators

There is a big difference between Entero Stock performing well and Entero Therapeutics, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Entero Therapeutics,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
KPRX	2.77	(0.29)	0.00	(0.26)	0.00	0.00	5.95	(4.97)	16.59
ZVSA	4.67	(0.99)	0.00	0.60	0.00	0.00	9.17	(10.36)	78.93
SONN	4.76	(0.77)	0.00	2.19	0.00	0.00	12.31	(9.79)	37.58
ZURA	3.78	(0.36)	0.00	(0.09)	0.00	0.00	7.95	(7.94)	30.69
PHIO	4.53	(0.30)	0.00	(0.18)	0.00	0.00	11.78	(10.38)	36.22
RNAZ	7.63	1.05	0.10	(0.44)	6.52	(11.84)	22.00	(11.43)	68.80
QNRX	6.21	0.47	0.07	0.37	6.73	(8.82)	17.65	(9.68)	74.46

Entero Therapeutics, Corporate Management

Jennifer SealeyVoyksner	Senior Development	Profile
Sarah CPA	Chief Officer	Profile
Amy ChandlerSkerkis	QA Affairs	Profile
Martin MBA	Senior Development	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC